Ligand Pharmaceuticals Incorporated (FRA:LGDN)
160.00
+4.00 (2.56%)
At close: Jan 30, 2026
42.86% (1Y)
| Market Cap | 3.18B +57.1% |
| Revenue (ttm) | 214.13M +64.8% |
| Net Income | 41.41M +7.4% |
| EPS | 2.12 +0.8% |
| Shares Out | n/a |
| PE Ratio | 76.86 |
| Forward PE | 23.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 6 |
| Open | 161.00 |
| Previous Close | 156.00 |
| Day's Range | 160.00 - 161.00 |
| 52-Week Range | 86.00 - 181.00 |
| Beta | n/a |
| RSI | 46.21 |
| Earnings Date | Feb 11, 2026 |